This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by O'Grady, J. T. Articles by Krajewski, A. S. Search for Related Content PubMed PubMed Citation Articles by O'Grady, J. T. Articles by Krajewski, A. S.

American Journal of Pathology, Vol 144, 21-26, Copyright © 1994 by American Society for Investigative Pathology

REGULAR ARTICLES

CD40 expression in Hodgkin's disease

JT O'Grady, S Stewart, J Lowrey, SE Howie and AS Krajewski
Department of Pathology, University of Edinburgh, United Kingdom.

CD40 is a transmembrane protein that belongs to a superfamily of proteins related to nerve growth factor receptor. CD40 is expressed on B cells and some B cell malignancies. It appears to be involved in B cell proliferation and the prevention of apoptosis in germinal center cells, which is accompanied by expression of bcl-2. Its expression is up-regulated by the EBV protein latent membrane protein-1 and cytokines interleukin-4 and interferon-gamma. The expression of CD40 in 37 cases of Hodgkin's disease and 23 cases of non-Hodgkin's lymphoma (11 T cell lymphomas and 12 B cell lymphomas) was examined by paraffin section immunohistochemistry using the BB-20 monoclonal antibody. In 26 of 37 cases of Hodgkin's disease the Reed-Sternberg cells showed strong membrane or cytoplasmic expression of CD40. Only 3 of 23 non-Hodgkin's lymphomas showed any expression of CD40 and then only weakly. There was no correlation between expression of bcl-2 or latent membrane protein-1 with CD40 expression. These results show that there is probable hyperexpression of CD40 in Hodgkin's disease and suggest that dysregulation of CD40 expression may play a role in the pathogenesis of Hodgkin's disease.

This article has been cited by other articles:

				C.-L. Law, K. A. Gordon, J. Collier, K. Klussman, J. A. McEarchern, C. G. Cerveny, B. J. Mixan, W. P. Lee, Z. Lin, P. Valdez, et al. Preclinical Antilymphoma Activity of a Humanized Anti-CD40 Monoclonal Antibody, SGN-40 Cancer Res., September 15, 2005; 65(18): 8331 - 8338. [Abstract] [Full Text] [PDF]

				B. F. Skinnider and T. W. Mak The role of cytokines in classical Hodgkin lymphoma Blood, May 29, 2002; 99(12): 4283 - 4297. [Abstract] [Full Text] [PDF]

				M. Hinz, P. Loser, S. Mathas, D. Krappmann, B. Dorken, and C. Scheidereit Constitutive NF-{kappa}B maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells Blood, May 1, 2001; 97(9): 2798 - 2807. [Abstract] [Full Text] [PDF]

				H. Durkop, H.-D. Foss, G. Demel, H. Klotzbach, C. Hahn, and H. Stein Tumor Necrosis Factor Receptor-Associated Factor 1 Is Overexpressed in Reed-Sternberg Cells of Hodgkin's Disease and Epstein-Barr Virus-Transformed Lymphoid Cells Blood, January 15, 1999; 93(2): 617 - 623. [Abstract] [Full Text] [PDF]

				J. A. Francisco, S. L. Gawlak, and C. B. Siegall Construction, Expression, and Characterization of BD1-G28-5 sFv, a Single-chain Anti-CD40 Immunotoxin Containing the Ribosome-inactivating Protein Bryodin 1 J. Biol. Chem., September 26, 1997; 272(39): 24165 - 24169. [Abstract] [Full Text] [PDF]

				J. A. Francisco, G. J. Schreiber, C. R. Comereski, L. E. Mezza, G. L. Warner, T. J. Davidson, J. A. Ledbetter, and C. B. Siegall In Vivo Efficacy and Toxicity of a Single-Chain Immunotoxin Targeted to CD40 Blood, June 15, 1997; 89(12): 4493 - 4500. [Abstract] [Full Text] [PDF]